These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11290555)

  • 1. Molecular clonality of in-transit melanoma metastasis.
    Nakayama T; Taback B; Turner R; Morton DL; Hoon DS
    Am J Pathol; 2001 Apr; 158(4):1371-8. PubMed ID: 11290555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal origin of lymph node metastases in bladder carcinoma.
    Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
    Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
    Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
    Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11q23 allelic loss is associated with regional lymph node metastasis in melanoma.
    Herbst RA; Mommert S; Casper U; Podewski EK; Kiehl P; Kapp A; Weiss J
    Clin Cancer Res; 2000 Aug; 6(8):3222-7. PubMed ID: 10955807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
    Fujiwara Y; Chi DD; Wang H; Keleman P; Morton DL; Turner R; Hoon DS
    Cancer Res; 1999 Apr; 59(7):1567-71. PubMed ID: 10197630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis.
    Takata M; Morita R; Takehara K
    Int J Cancer; 2000 Feb; 85(4):492-7. PubMed ID: 10699920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
    Taback B; Fujiwara Y; Wang HJ; Foshag LJ; Morton DL; Hoon DS
    Cancer Res; 2001 Aug; 61(15):5723-6. PubMed ID: 11479206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic analysis of primary and metastatic cutaneous melanoma.
    Rao UN; Jones MW; Finkelstein SD
    Cancer Genet Cytogenet; 2003 Jan; 140(1):37-44. PubMed ID: 12550756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of allelic deletions within melanoma metastases.
    Bogdan I; Xin H; Burg G; Böni R
    Melanoma Res; 2001 Aug; 11(4):349-54. PubMed ID: 11479423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
    Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
    Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q.
    Lin YW; Lee HS; Chen CH; Huang GT; Lee PH; Sheu JC
    J Gastroenterol Hepatol; 2005 Apr; 20(4):536-46. PubMed ID: 15836701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of microsatellite alterations in plasma DNA of malignant mucosal melanoma using whole genome amplification.
    Nakamoto D; Yamamoto N; Takagi R; Katakura A; Mizoe JE; Shibahara T
    Bull Tokyo Dent Coll; 2008 May; 49(2):77-87. PubMed ID: 18776719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOH analysis of free DNA in the plasma of patients with mucosal malignant melanoma in the head and neck.
    Takagi R; Nakamoto D; Mizoe JE; Tsujii H
    Int J Clin Oncol; 2007 Jun; 12(3):199-204. PubMed ID: 17566843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal origin of metastatic testicular teratomas.
    Jones TD; Wang M; Sung MT; Zhang S; Ulbright TM; Eble JN; Beck SD; Foster RS; Anagnostou JJ; Conner C; Cheng L
    Clin Cancer Res; 2006 Sep; 12(18):5377-83. PubMed ID: 16982812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of the role of chromosome 9p21 in sporadic melanoma through genetic analysis of primary tumours and their metastases. The Melanoma Cooperative Group.
    Palmieri G; Cossu A; Ascierto PA; Botti G; Strazzullo M; Lissia A; Colombino M; Casula M; Floris C; Tanda F; Pirastu M; Castello G;
    Br J Cancer; 2000 Dec; 83(12):1707-14. PubMed ID: 11104570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.
    Pollock PM; Welch J; Hayward NK
    Cancer Res; 2001 Feb; 61(3):1154-61. PubMed ID: 11221846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
    Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detailed deletion mapping of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis.
    Xu XF; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Aug; 117(8):1204-9. PubMed ID: 15361296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.